Latest news with #BoardResignation
Yahoo
a day ago
- Business
- Yahoo
Bausch + Lomb Announces Board Changes
VAUGHAN, Ontario, August 18, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursuant to its terms when the Icahn group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., fell below the required threshold. In connection with the termination, Brett M. Icahn and Gary Hu have resigned from the Bausch + Lomb Board of Directors. "I appreciate Brett and Gary's valuable contributions to the company over the past three years, and wish them well going forward," said Brent Saunders, chairman and CEO, Bausch + Lomb. About Bausch + LombBausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on Facebook, Instagram, LinkedIn, X and YouTube. © 2025 Bausch + Lomb View source version on Contacts Media Contact: Chris (848) 360-1100 Investor Contact: George (877) 354-3705 (toll free)(908) 927-0735
Reuters
2 days ago
- Business
- Reuters
Icahn representations resign Bausch + Lomb board after agreement termination
Aug 18 (Reuters) - Contact lens maker Bausch + Lomb ( opens new tab said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire investor Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group's net long position in Bausch Health Companies ( opens new tab, Bausch + Lomb's parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital, along with certain affiliates and managed funds, acquired about 34.7 million common shares previously held by the Icahn Group, and now owns about 19.13% of the company's outstanding common shares. The company added Brett Icahn and Steven Miller resigned from Bausch Health's board, following the termination of a separate director appointment and nomination agreement dated February 23, 2021. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health's shares. Bausch Health separated Bausch + Lomb into another publicly listed company in 2022 while retaining a majority stake. It holds an 87.7% stake, according to data compiled by LSEG.
National Post
2 days ago
- Business
- National Post
Bausch + Lomb Announces Board Changes
Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursuant to its terms when the Icahn group's net long position in the common shares of Bausch + Lomb's parent company, Bausch Health Companies Inc., fell below the required threshold. In connection with the termination, Brett M. Icahn and Gary Hu have resigned from the Bausch + Lomb Board of Directors. Article content 'I appreciate Brett and Gary's valuable contributions to the company over the past three years, and wish them well going forward,' said Brent Saunders, chairman and CEO, Bausch + Lomb. Article content Article content About Bausch + Lomb Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content © 2025 Bausch + Lomb Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Chris Clark Article content Article content Article content Article content (848) 360-1100 Article content Investor Contact: Article content Article content George Gadkowski Article content Article content Article content
